Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study

BACKGROUND: Protease inhibitor monotherapy is associated with more frequent episodes of viral rebounds above 50 copies/mL than triple therapy. Objective: To evaluate if, compared to triple-drug therapy, protease inhibitor monotherapy is associated with increased levels of inflammatory/procoagulant m...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Estébanez, Miriam, Stella-Ascariz, Natalia, Mingorance, Jesús, Pérez-Valero, Ignacio, Bernardino, Jose Ignacio, Zamora, Francisco Xavier, Montes, Maria Luisa, González-García, Juan Julián, Arribas, José Ramón
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4097047/
https://ncbi.nlm.nih.gov/pubmed/25015544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-379
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky